Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Alzheimer’s disease could be inhibited by protein CD33

Staff Writer
Staff Writer 4 years ago
Updated 2019/12/15 at 11:27 PM
Share
SHARE

A new study unveiled how a protein in the brain known as CD33 may be an important factor against Alzheimer’s disease (AD), according to researchers at the University of Alberta.

The study, released online in the peer-reviewed journal Communications Biology, set out to determine if CD33, a protein that regulates white blood cells in the brain, could lower the risk of developing Alzheimer’s disease. Microglia, immune cells in the brain linked to the neurodegenerative disease, was also probed.

Based on the findings, conducted on rodents, “The strong genetic link between variants of CD33 and AD susceptibility suggests that targeting the common risk allele of CD33, which preferentially encodes the longer isoform (hCD33M) containing its glycan-binding domain, could be a treatment strategy in neurodegenerative disease,” the findings read.

CD33 is commonly found on microglia, and as a result, immune cells could be a factor in inhibiting Alzheimer’s, researchers suggest.

“The fact that CD33 is found on microglia suggests that immune cells can protect the brain from Alzheimer’s disease under the right circumstances.”

“Our findings demonstrate that expression of the long isoform of hCD33 (hCD33M) alone is sufficient to repress phagocytosis in both monocytes and microglia,” the study concluded.

“These findings set the stage for future testing of a causal relationship between CD33 and Alzheimer’s Disease, as well as testing therapeutic strategies to sway microglia from harmful to protecting against the disease – by targeting CD33.”

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

Study claims the more people think God, the more likely they trust AI decision-making

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

TAGGED: CD33, Alzheimer's disease, cognition
Staff Writer December 15, 2019
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Lowering consumption of sugary sweets may alleviate symptoms of holiday blues
Next Article A diet of high-sugar and refined carbohydrates could raise the risk of insomnia

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Cyber

Study claims the more people think God, the more likely they trust AI decision-making

2 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?